Curiox BioSystems Co Ltd experienced a single notable transaction within the last ninety days. Representative Director Nam Yong Kim executed a planned sale of 388,513 shares, totaling approximately 23 billion KRW. This divestment occurred amidst a period where the stock price appreciated by 49.1 percent, reflecting significant market volatility for the healthcare entity.